Cargando…
Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India
PURPOSE: To assess the proportion of people with type 2 diabetes mellitus (T2DM) with diabetic retinopathy (DR) and sight-threatening DR (STDR) and associated risk factors in select eye-care facilities across India. METHODS: In this observational study, data of people with T2DM presenting for the fi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001176/ https://www.ncbi.nlm.nih.gov/pubmed/31937724 http://dx.doi.org/10.4103/ijo.IJO_21_19 |
_version_ | 1783494184596930560 |
---|---|
author | Rajalakshmi, Ramachandran Behera, Umesh C Bhattacharjee, Harsha Das, Taraprasad Gilbert, Clare Murthy, G V S Pant, Hira B Shukla, Rajan |
author_facet | Rajalakshmi, Ramachandran Behera, Umesh C Bhattacharjee, Harsha Das, Taraprasad Gilbert, Clare Murthy, G V S Pant, Hira B Shukla, Rajan |
author_sort | Rajalakshmi, Ramachandran |
collection | PubMed |
description | PURPOSE: To assess the proportion of people with type 2 diabetes mellitus (T2DM) with diabetic retinopathy (DR) and sight-threatening DR (STDR) and associated risk factors in select eye-care facilities across India. METHODS: In this observational study, data of people with T2DM presenting for the first time at the retina clinic of eye-care facilities across India was recorded. Data collected in 2016 over 6 months included information on systemic, clinical, and ocular parameters. International Clinical Diabetic Retinopathy (ICDR) classification scale was used to grade DR. STDR was defined as presence of severe nonproliferative (NPDR), proliferative diabetic retinopathy (PDR), and/or diabetic macular edema (DME). RESULTS: The analysis included 11,182 people with T2DM from 14 eye-care facilities (mean age 58.2 ± 10.6 years; mean duration of diabetes 9.1 ± 7.6 years; 59.2% male). The age-standardized proportion of DR was 32.3% (95%Confidence Interval, CI: 31.4-33.2) and STDR was 19.1% (95%CI: 18.4-19.8). DME was diagnosed in 9.1% (95%CI: 8.5-9.6) and 10.7% (95%CI: 10.1-11.3) people had PDR. Statistically significant factors associated with increased risk of DR (by multivariate logistic regression analysis) were: male gender (Odds ratio[OR] 1.57, 95%CI: 1.16-2.15); poor glycemic control–glycated hemoglobin (HbA1c >10%)(OR 2.39, 95% CI: 1.1-5.22); requirement of insulin (OR 2.55, 95%CI: 1.8-3.6);history of hypertension (OR 1.42, 95%CI: 1.06-1.88) and duration of diabetes >15 years (OR 5.25, 95%CI: 3.01-9.15). CONCLUSION: Diabetic retinopathy was prevalent in 1/3(rd) and sight-threatening DR in 1/5(th) of people with T2DM presenting at eye-care facilities in this pan-India facility-based study. The duration of diabetes was the strongest predictor for retinopathy. |
format | Online Article Text |
id | pubmed-7001176 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-70011762020-02-13 Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India Rajalakshmi, Ramachandran Behera, Umesh C Bhattacharjee, Harsha Das, Taraprasad Gilbert, Clare Murthy, G V S Pant, Hira B Shukla, Rajan Indian J Ophthalmol Original Article PURPOSE: To assess the proportion of people with type 2 diabetes mellitus (T2DM) with diabetic retinopathy (DR) and sight-threatening DR (STDR) and associated risk factors in select eye-care facilities across India. METHODS: In this observational study, data of people with T2DM presenting for the first time at the retina clinic of eye-care facilities across India was recorded. Data collected in 2016 over 6 months included information on systemic, clinical, and ocular parameters. International Clinical Diabetic Retinopathy (ICDR) classification scale was used to grade DR. STDR was defined as presence of severe nonproliferative (NPDR), proliferative diabetic retinopathy (PDR), and/or diabetic macular edema (DME). RESULTS: The analysis included 11,182 people with T2DM from 14 eye-care facilities (mean age 58.2 ± 10.6 years; mean duration of diabetes 9.1 ± 7.6 years; 59.2% male). The age-standardized proportion of DR was 32.3% (95%Confidence Interval, CI: 31.4-33.2) and STDR was 19.1% (95%CI: 18.4-19.8). DME was diagnosed in 9.1% (95%CI: 8.5-9.6) and 10.7% (95%CI: 10.1-11.3) people had PDR. Statistically significant factors associated with increased risk of DR (by multivariate logistic regression analysis) were: male gender (Odds ratio[OR] 1.57, 95%CI: 1.16-2.15); poor glycemic control–glycated hemoglobin (HbA1c >10%)(OR 2.39, 95% CI: 1.1-5.22); requirement of insulin (OR 2.55, 95%CI: 1.8-3.6);history of hypertension (OR 1.42, 95%CI: 1.06-1.88) and duration of diabetes >15 years (OR 5.25, 95%CI: 3.01-9.15). CONCLUSION: Diabetic retinopathy was prevalent in 1/3(rd) and sight-threatening DR in 1/5(th) of people with T2DM presenting at eye-care facilities in this pan-India facility-based study. The duration of diabetes was the strongest predictor for retinopathy. Wolters Kluwer - Medknow 2020-02 2020-01-17 /pmc/articles/PMC7001176/ /pubmed/31937724 http://dx.doi.org/10.4103/ijo.IJO_21_19 Text en Copyright: © 2020 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Rajalakshmi, Ramachandran Behera, Umesh C Bhattacharjee, Harsha Das, Taraprasad Gilbert, Clare Murthy, G V S Pant, Hira B Shukla, Rajan Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India |
title | Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India |
title_full | Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India |
title_fullStr | Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India |
title_full_unstemmed | Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India |
title_short | Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India |
title_sort | spectrum of eye disorders in diabetes (speed) in india. report # 2. diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001176/ https://www.ncbi.nlm.nih.gov/pubmed/31937724 http://dx.doi.org/10.4103/ijo.IJO_21_19 |
work_keys_str_mv | AT rajalakshmiramachandran spectrumofeyedisordersindiabetesspeedinindiareport2diabeticretinopathyandriskfactorsforsightthreateningdiabeticretinopathyinpeoplewithtype2diabetesinindia AT beheraumeshc spectrumofeyedisordersindiabetesspeedinindiareport2diabeticretinopathyandriskfactorsforsightthreateningdiabeticretinopathyinpeoplewithtype2diabetesinindia AT bhattacharjeeharsha spectrumofeyedisordersindiabetesspeedinindiareport2diabeticretinopathyandriskfactorsforsightthreateningdiabeticretinopathyinpeoplewithtype2diabetesinindia AT dastaraprasad spectrumofeyedisordersindiabetesspeedinindiareport2diabeticretinopathyandriskfactorsforsightthreateningdiabeticretinopathyinpeoplewithtype2diabetesinindia AT gilbertclare spectrumofeyedisordersindiabetesspeedinindiareport2diabeticretinopathyandriskfactorsforsightthreateningdiabeticretinopathyinpeoplewithtype2diabetesinindia AT murthygvs spectrumofeyedisordersindiabetesspeedinindiareport2diabeticretinopathyandriskfactorsforsightthreateningdiabeticretinopathyinpeoplewithtype2diabetesinindia AT panthirab spectrumofeyedisordersindiabetesspeedinindiareport2diabeticretinopathyandriskfactorsforsightthreateningdiabeticretinopathyinpeoplewithtype2diabetesinindia AT shuklarajan spectrumofeyedisordersindiabetesspeedinindiareport2diabeticretinopathyandriskfactorsforsightthreateningdiabeticretinopathyinpeoplewithtype2diabetesinindia AT spectrumofeyedisordersindiabetesspeedinindiareport2diabeticretinopathyandriskfactorsforsightthreateningdiabeticretinopathyinpeoplewithtype2diabetesinindia |